Ftse Mib
34.083,91
0,75%
DAX
20.232,14
0,98%
S&P 500
6.086,49
0,61%
NASDAQ
19.735,12
1,30%
Bitcoin
102.981,18
4,28%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ AVROBIO Inc (AVRO) AVROBIO Inc (AVRO) Notizie

AVRO

AVROBIO (AVRO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AVRO
DataOraFonteTitoloSimboloCompagnia
18/06/202417:51Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AVROAVROBIO Inc
14/06/202422:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVROAVROBIO Inc
04/06/202415:31Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AVROAVROBIO Inc
09/05/202422:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVROAVROBIO Inc
06/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AVROAVROBIO Inc
27/02/202416:50PR Newswire (US)Kuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to Contact Law FirmNASDAQ:AVROAVROBIO Inc
23/02/202422:00Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AVROAVROBIO Inc
06/02/202402:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVROAVROBIO Inc
01/02/202420:25PR Newswire (US)Kuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to Contact Law FirmNASDAQ:AVROAVROBIO Inc
30/01/202414:00Business WireAVROBIO and Tectonic Therapeutic Announce MergerNASDAQ:AVROAVROBIO Inc
03/11/202321:15Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:AVROAVROBIO Inc
12/07/202313:00Business WireAVROBIO to Explore Strategic AlternativesNASDAQ:AVROAVROBIO Inc
14/06/202323:20Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AVROAVROBIO Inc
12/06/202313:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVROAVROBIO Inc
12/06/202313:00Business WireAVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 MillionNASDAQ:AVROAVROBIO Inc
08/06/202322:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVROAVROBIO Inc
07/06/202318:07Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:AVROAVROBIO Inc
22/05/202313:00Business WireAVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 MillionNASDAQ:AVROAVROBIO Inc
18/05/202314:14Dow Jones NewsAvrobio Stock Up 16% on Positive Data for Cystinosis TreatmentNASDAQ:AVROAVROBIO Inc
18/05/202313:00Business WireAVROBIO Announces Positive Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Cystinosis at the ASGCT 26th Annual MeetingNASDAQ:AVROAVROBIO Inc
11/05/202313:00Business WireAVROBIO Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:AVROAVROBIO Inc
05/05/202322:01Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:AVROAVROBIO Inc
01/05/202323:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AVROAVROBIO Inc
01/05/202313:30Business WireAVROBIO Announces Leadership TransitionNASDAQ:AVROAVROBIO Inc
23/03/202321:59Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AVROAVROBIO Inc
23/03/202321:37Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AVROAVROBIO Inc
23/03/202312:00Business WireAVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business UpdateNASDAQ:AVROAVROBIO Inc
03/03/202313:00Business WireAVROBIO to Participate in Cowen’s 43rd Annual Health Care ConferenceNASDAQ:AVROAVROBIO Inc
09/02/202313:00Business WireAVROBIO to Present Clinical and Preclinical Data from Lysosomal Disorder Gene Therapy Pipeline at WORLDSymposium™ 2023NASDAQ:AVROAVROBIO Inc
08/02/202312:05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AVROAVROBIO Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AVRO

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
CPR
Davide Campari
BIT
ENI
Eni
BIT
BAMI
Banco BPM
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STMMI
ST Microelectronics
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
PRY
Prysmian
BIT
LDO
Leonardo
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network